Resultats globals: 8 registres trobats en 0.02 segons.
Articles, 7 registres trobats
Documents de recerca, 1 registres trobats
Articles 7 registres trobats  
1.
4 p, 417.7 KB Correction to : A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity / van der Lee, Sven J. (Vrije Universiteit Amsterdam, Amsterdam UMC. Department of Clinical Genetics) ; Conway, Olivia J. (Mayo Clinic Florida. Department of Neuroscience) ; Jansen, Iris (Vrije Universiteit Amsterdam, Amsterdam UMC. Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience) ; Carrasquillo, Minerva M. (Mayo Clinic Florida. Department of Neuroscience) ; Kleineidam, Luca (University Hospital Cologne. Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine) ; van den Akker, Erik (Delft University of Technology. Pattern Recognition and Bioinformatics) ; Hernández, Isabel (Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED)) ; van Eijk, Kristel R. (University Medical Center Utrecht. Department of Neurology, Brain Center Rudolf Magnus) ; Stringa, Najada (Amsterdam Public Health Research Institute. Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Epidemiology and Biostatistics) ; Chen, Jason A. (University of California. Interdepartmental Program in Bioinformatics) ; Zettergren, Anna (Neuropsychiatric Epidemiology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Centre for Ageing and Health (AgeCap) at the University of Gothenburg) ; Andlauer, Till F. M. (German Competence Network Multiple Sclerosis (KKNMS)) ; Diez-Fairen, Monica (Fundacio per la Recerca Biomedica I Social Mutua Terrassa) ; Simon-Sanchez, Javier (University of Tübingen. Hertie Institute for Clinical Brain Research) ; Lleó, Alberto (Universitat Autonoma de Barcelona. Memory Unit, Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau) ; Zetterberg, Henrik (UCL Institute of Neurology, Queen Square. Department of Molecular Neuroscience) ; Nygaard, Marianne (University of Southern Denmark. The Danish Aging Research Center, Epidemiology, Biostatistics and Biodemography, Department of Public Health) ; Blauwendraat, Cornelis (National Institute of Neurological Disorders and Stroke. Neurodegenerative Diseases Research Unit) ; Savage, Jeanne E. (Vrije Universiteit Amsterdam, Amsterdam UMC. Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience) ; Mengel-From, Jonas (University of Southern Denmark. Epidemiology, Biostatistics and Biodemography, Department of Public Health) ; Moreno-Grau, Sonia (Universitat Internacional de Catalunya. Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades) ; Wagner, Michael (DZNE, German Center for Neurodegenerative Diseases) ; Fortea, Juan (Universitat Autonoma de Barcelona. Memory Unit, Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau) ; Keogh, Michael J. (University of Cambridge. Department of Clinical Neurosciences) ; Blennow, Kaj (Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg. Department of Psychiatry and Neurochemistry) ; Skoog, Ingmar (Neuropsychiatric Epidemiology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Centre for Ageing and Health (AgeCap) at the University of Gothenburg) ; Friese, Manuel A. (Universitätsklinikum Hamburg-Eppendorf. Institut für Neuroimmunologie und Multiple Sklerose (INIMS)) ; Pletnikova, Olga (Johns Hopkins University Medical Center. Department of Pathology (Neuropathology)) ; Zulaica, Miren (Instituto Biodonostia) ; Lage, Carmen (IDIVAL) ; de Rojas, Itziar (Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED)) ; Riedel-Heller, Steffi (University of Leipzig. Institute of Social Medicine, Occupational Health and Public Health (ISAP)) ; Illán-Gala, Ignacio (Universitat Autonoma de Barcelona. Memory Unit, Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau) ; Wei, Wei (University of Cambridge. Department of Clinical Neurosciences) ; Jeune, Bernard (University of Southern Denmark. Epidemiology, Biostatistics and Biodemography, Department of Public Health) ; Orellana, Adelina (Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED)) ; Then Bergh, Florian (University of Leipzig. Department of Neurology) ; Wang, Xue (Mayo Clinic Florida. Department of Neuroscience) ; Hulsman, Marc (Delft University of Technology. Pattern Recognition and Bioinformatics) ; Beker, Nina (Vrije Universiteit Amsterdam, Amsterdam UMC. Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience) ; Tesi, Niccolo (Delft University of Technology. Pattern Recognition and Bioinformatics) ; Morris, Christopher M. (Newcastle University. Newcastle Brain Tissue Resource, Edwardson Building, Institute of Neuroscience) ; Indakoetxea, Begoña (Cognitive Disorders Unit, Department of Neurology, Hospital Universitario San Sebastian, San Sebastian, Spain) ; Collij, Lyduine E. (Vrije Universiteit Amsterdam, Amsterdam UMC. Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience) ; Scherer, Martin (Department of Primary Medical Care, Center for Psychosocial Medicine, University Medical Center, Hamburg-Eppendorf, Germany) ; Morenas-Rodríguez, Estrella (Universitat Autonoma de Barcelona. Memory Unit, Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau) ; Ironside, James W. (University of Edinburgh. Centre for Clinical Brain Sciences) ; van Berckel, Bart N. M. (Vrije Universiteit Amsterdam, Amsterdam UMC. Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience) ; Alcolea, Daniel (Universitat Autonoma de Barcelona. Memory Unit, Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau) ; Wiendl, Heinz (University of Münster. Department of Neurology, Klinik für Neurologie mit Institut für Translationale Neurologie) ; Strickland, Samantha L. (Mayo Clinic Florida. Department of Neuroscience) ; Pastor, Pau (Fundacio per la Recerca Biomedica I Social Mutua Terrassa) ; Rodríguez Rodríguez, Eloy (IDIVAL) ; Boeve, Bradley F. (Mayo Clinic Minnesota. Department of Neurology) ; Petersen, Ronald C. (Mayo Clinic Minnesota. Department of Neurology) ; Ferman, Tanis J. (Mayo Clinic Florida. Department of Psychiatry and Psychology) ; van Gerpen, Jay A. (Mayo Clinic Florida. Department of Neurology) ; Reinders, Marcel J. T. (Delft University of Technology. Delft Bioinformatics Lab) ; Uitti, Ryan J. (Mayo Clinic Florida. Department of Neurology) ; Tárraga, Lluís (Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED)) ; Maier, Wolfgang (DZNE, German Center for Neurodegenerative Diseases) ; Dols-Icardo, Oriol (Universitat Autonoma de Barcelona. Memory Unit, Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau) ; Kawalia, Amit (University Hospital Cologne. Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine) ; Dalmasso, Maria Carolina (Fundación Instituto Leloir-IIBBA-CONICET) ; Boada, Mercè (Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED)) ; Zettl, Uwe K. (University of Rostock. Department of Neurology) ; van Schoor, Natasja M. (Amsterdam Public Health Research Institute. Amsterdam UMC-Vrije Universiteit Amsterdam, Department of Epidemiology and Biostatistics) ; Beekman, Marian (Leiden University Medical Center. Molecular Epidemiology) ; Allen, Mariet (Mayo Clinic Florida. Department of Neuroscience) ; Masliah, Eliezer (National Institute on Aging, National Institutes of Health. Laboratory of Neurogenetics) ; de Munain, Adolfo López (Department of Neurology, Hospital Universitario San Sebastian, San Sebastian, Spain) ; Pantelyat, Alexander (Johns Hopkins University Medical Center. Department of Neurology) ; Wszolek, Zbigniew K. (Mayo Clinic Florida. Department of Neurology) ; Ross, Owen A. (Mayo Clinic Florida. Department of Neuroscience) ; Dickson, Dennis W. (Mayo Clinic Florida. Department of Neuroscience) ; Graff-Radford, Neill R. (Mayo Clinic Florida. Department of Neurology) ; Knopman, David (Mayo Clinic Minnesota. Department of Neurology) ; Rademakers, Rosa (Mayo Clinic Florida. Department of Neuroscience) ; Lemstra, Afina W. (Vrije Universiteit Amsterdam, Amsterdam UMC. Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience) ; Pijnenburg, Yolande A. L. (Vrije Universiteit Amsterdam, Amsterdam UMC. Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience) ; Scheltens, Philip (Vrije Universiteit Amsterdam, Amsterdam UMC. Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience) ; Gasser, Thomas (University of Tuebingen. Center of Neurology, Department of Neurodegenerative diseases, Hertie-Institute for Clinical Brain Research) ; Chinnery, Patrick F (University of Cambridge. MRC Mitochondrial Biology Unit) ; Hemmer, Bernhard (Munich Cluster for Systems Neurology (SyNergy)) ; Huisman, Martijn A. (VU University. Department of Sociology) ; Troncoso, Juan (Johns Hopkins University Medical Center. Department of Pathology (Neuropathology)) ; Moreno, Fermin (Cognitive Disorders Unit, Department of Neurology, Hospital Universitario San Sebastian, San Sebastian, Spain) ; Nohr, Ellen A. (University of Southern Denmark. Research Unit of Gynecology and Obstetrics, Department of Clinical Research) ; Sørensen, Thorkild I. A. (Bristol University. MRC Integrative Epidemiology Unit) ; Heutink, Peter (University of Tübingen. Hertie Institute for Clinical Brain Research) ; Sánchez-Juan, Pascual (IDIVAL) ; Posthuma, Danielle (Vrije Universiteit Amsterdam, Amsterdam UMC. Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience) ; Clarimón, Jordi (Universitat Autonoma de Barcelona. Memory Unit, Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau) ; Christensen, Kaare (Odense University Hospital. Department of Clinical Genetics) ; Ertekin-Taner, Nilüfer (Mayo Clinic Florida. Department of Neurology) ; Scholz, Sonja W. (Johns Hopkins University Medical Center. Department of Neurology) ; Ramirez, Alfredo (University Hospital Cologne. Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine) ; Ruiz, Agustín (Centro de Investigacion Biomedica en Red en Enfermedades Neurodegenerativas (CIBERNED)) ; Slagboom, Eline (Dutch Society for Research on Ageing, Leiden, The Netherlands) ; van der Flier, Wiesje M. (Vrije Universiteit Amsterdam, Amsterdam UMC. Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience) ; Holstege, Henne (Vrije Universiteit Amsterdam, Amsterdam UMC. Department of Clinical Genetics)
2020 Department of Psychiatry, - 10.1007/s00401-019-02026-8
Acta Neuropathologica, Vol. 139 (january 2020) , p. 959-962  
2.
10 p, 92.4 KB Social Representation of Dementia : An Analysis of 5,792 Consecutive Cases Evaluated in a Memory Clinic / Cañabate, Pilar (Institut Català de Neurociènces Aplicades) ; Martínez, Gabriel (University of Antofagasta) ; Rosende-Roca, Maitée (Institut Català de Neurociènces Aplicades) ; Moreno, Mariola (Institut Català de Neurociènces Aplicades) ; Preckler, Silvia (Institut Català de Neurociènces Aplicades) ; Valero Ventura, Sergi (Hospital Universitari Vall d'Hebron) ; Sotolongo Grau, Oscar (Institut Català de Neurociènces Aplicades) ; Hernández, Isabel (Institut Català de Neurociènces Aplicades) ; Alegret, Montserrat (Institut Català de Neurociènces Aplicades) ; Ortega Linares, Gemma (Institut Català de Neurociènces Aplicades) ; Espinosa, Ana (Institut Català de Neurociènces Aplicades) ; Mauleón, Ana (Institut Català de Neurociènces Aplicades) ; Vargas, Liliana (Institut Català de Neurociènces Aplicades) ; Rodríguez, Octavio (Institut Català de Neurociènces Aplicades) ; Abdelnour, Carla (Institut Català de Neurociènces Aplicades) ; Sánchez, Domingo (Institut Català de Neurociènces Aplicades) ; Martín, Elvira (Institut Català de Neurociènces Aplicades) ; Ruiz, Agustín (Institut Català de Neurociènces Aplicades) ; Tárraga, Lluís (Institut Català de Neurociènces Aplicades) ; Boada Rovira, Mercè (Institut Català de Neurociènces Aplicades) ; Universitat Autònoma de Barcelona
Background: Different interpretations of cognitive impairment and dementia due to differences in health structures, such as cultural differences could affect the diagnosis and treatment of the condition. [...]
2017 - 10.3233/JAD-161119
Journal of Alzheimer's disease, Vol. 58, Núm. 4 (June 2017) , p. 1099-1108  
3.
13 p, 129.1 KB Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype / Espinosa, Ana (Institut Català de Neurociències Aplicades) ; Alegret, Montserrat (Institut Català de Neurociències Aplicades) ; Pesini, Pedro (Araclon Biotech S.L.) ; Valero Ventura, Sergi (Hospital Universitari Vall d'Hebron) ; Lafuente, Asunción (Institut Català de Neurociències Aplicades) ; Buendía, Mar (Institut Català de Neurociències Aplicades) ; San José, Itziar (Araclon Biotech S.L.) ; Ibarria, Marta (Institut Català de Neurociències Aplicades) ; Tejero, Miguel A. (Clínica Corachán) ; Giménez Ruiz, Joan (Clínica Corachán) ; Ruiz, Susana (Institut Català de Neurociències Aplicades) ; Hernández, Isabel (Institut Català de Neurociències Aplicades) ; Pujadas, Francesc (Hospital Universitari Vall d'Hebron) ; Martínez Lage, Pablo (Fundación CITA) ; Munuera del Cerro, Josep (Hospital Universitari Germans Trias i Pujol) ; Arbizu, Javier (Clínica Universitaria de Pamplona) ; Tárraga, Lluís (Institut Català de Neurociències Aplicades) ; Hendrix, Suzanne B. (Pentara Corporation) ; Ruiz, Agustín (Institut Català de Neurociències Aplicades) ; Becker, James T. (University of Pittsburgh) ; Landau, Susan M. (University of California) ; Sotolongo Grau, Oscar (Institut Català de Neurociències Aplicades) ; Sarasa, Manuel (Araclon Biotech S.L.) ; Boada Rovira, Mercè (Institut Català de Neurociències Aplicades) ; Universitat Autònoma de Barcelona
The probable-amnestic (Pr-a) mild cognitive impairment (MCI)-storage subtype is a phenotype with 8. 5 times more risk of conversion to dementia, mainly Alzheimer's disease (AD), than the possible non-amnestic (Pss-na) MCI. [...]
2017 - 10.3233/JAD-161223
Journal of Alzheimer's disease, Vol. 57, Núm. 2 (March 2017) , p. 447-459  
4.
13 p, 955.5 KB TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis / van der Zee, Julie (University of Antwerp) ; Gijselinck, Ilse (University of Antwerp) ; Van Mossevelde, Sara (Antwerp University Hospital) ; Perrone, Federica (University of Antwerp) ; Dillen, Lubina (University of Antwerp) ; Heeman, Bavo (University of Antwerp) ; Bäumer, Veerle (University of Antwerp) ; Engelborghs, Sebastiaan (Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken) ; De Bleecker, Jan (University Hospital Ghent and University of Ghent) ; Baets, Jonathan (Antwerp University Hospital) ; Gelpi, Ellen (Neurological Tissue Bank of the Biobanc - Hospital Clinic-Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)) ; Rojas García, Ricardo (Universitat Autònoma de Barcelona) ; Clarimon, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Lleó Bisa, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Diehl-Schmid, Janine (Technische Universität München) ; Alexopoulos, Panagiotis (Technische Universität München) ; Perneczky, Robert (West London Mental Health Trust) ; Synofzik, Matthis (German Research Center for Neurodegenerative Diseases (DZNE)) ; Just, Jennifer (German Research Center for Neurodegenerative Diseases (DZNE)) ; Schöls, Ludger (German Research Center for Neurodegenerative Diseases (DZNE)) ; Graff, Caroline (Karolinska University Hospital) ; Thonberg, Håkan (Karolinska University Hospital) ; Borroni, Barbara (University of Brescia) ; Padovani, Alessandro (University of Brescia) ; Jordanova, Albena (Medical University-Sofia) ; Sarafov, Stayko (Medical University-Sofia) ; Tournev, Ivailo (New Bulgarian University) ; de Mendonça, Alexandre (University of Lisbon) ; Miltenberger-Miltényi, Gabriel (University of Lisbon) ; Simões do Couto, Frederico (University of Lisbon) ; Ramirez, Alfredo (University of Cologne) ; Jessen, Frank (German Center for Neurodegenerative Diseases (DZNE)) ; Heneka, Michael T. (University of Bonn) ; Gómez-Tortosa, Estrella (Fundación Jiménez Díaz) ; Danek, Adrian (German Center for Neurodegenerative Diseases (DZNE)) ; Cras, Patrick (Antwerp University Hospital) ; Vandenberghe, Rik (University Hospitals Leuven) ; De Jonghe, Peter (Antwerp University Hospital) ; De Deyn, Peter P. (Hospital Network Antwerp) ; Sleegers, Kristel (University of Antwerp) ; Cruts, Marc (University of Antwerp) ; Van Broeckhoven, Christine (University of Antwerp) ; Goeman, Johan (Hospital Network Antwerp) ; Nuytten, Dirk (Hospital Network Antwerp) ; Smets, Katrien (Antwerp University Hospital) ; Robberecht, Wim (University Hospitals Leuven Gasthuisberg) ; Damme, Philip Van (University Hospitals Leuven Gasthuisberg) ; Bleecker, Jan De (University Hospital Ghent) ; Santens, Patrick (University Hospital Ghent) ; Dermaut, Bart (University Hospital Ghent) ; Versijpt, Jan (University Hospital Brussels) ; Michotte, Alex (University Hospital Brussels) ; Ivanoiu, Adrian (Saint-Luc University Hospital) ; Deryck, Olivier (General Hospital Sint-Jan Brugge) ; Bergmans, Bruno (General Hospital Sint-Jan Brugge) ; Delbeck, Jean (General Hospital Sint-Maria) ; Bruyland, Marc (General Hospital Glorieux Ronse) ; Willems, Christiana (Jessa Hospital) ; Salmon, Eric (University of Liège and Memory Clinic) ; Pastor, Pau (CIBERNED Instituto de Salud Carlos III) ; Ortega-Cubero, Sara (Deparment of Neurology, Complejo Asistencial Universitario de Palencia) ; Benussi, Luisa (Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Ghidoni, Roberta (Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Binetti, Giuliano (MAC Memory Center and Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Hernández, Isabel (Fundació ACE, Institut Català de Neurociències Aplicades) ; Boada Rovira, Mercè (Fundació ACE, Institut Català de Neurociències Aplicades) ; Ruiz Laza, Agustín (Fundació ACE, Institut Català de Neurociències Aplicades) ; Sorbi, Sandro (Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence) ; Nacmias, Benedetta (Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence) ; Bagnoli, Silvia (Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence) ; Sorbi, Sandro (IRCCS Don Carlo Gnocchi Scandicci) ; Sánchez Valle, Raquel (Hospital Clínic, IDIBAPS) ; Lladó, Albert (Hospital Clínic, IDIBAPS) ; Santana, Isabel (University of Coimbra) ; Rosário Almeida, Maria (University of Coimbra) ; Frisoni, Giovanni B (Hôpitaux Universitaires de Genève et Université de Genève, Genève, Switzerland and IRCCS Fatebenefratelli) ; Maetzler, Walter (Hertie Institute for Clinical Brain Research) ; Matej, Radoslav (Thomayer Hospital, Prague and Charles University) ; Fraidakis, Matthew J. (NeuroRARE Centre for Rare and Genetic Neurological & Neuromuscular Diseases & Neurogenetics) ; Kovacs, Gabor G. (Medical University of Vienna) ; Fabrizi, Gian Maria (University of Verona) ; Testi, Silvia (University of Verona)
We investigated the mutation spectrum of the TANK-Binding Kinase 1 (TBK1) gene and its associated phenotypic spectrum by exonic resequencing of TBK1 in a cohort of 2,538 patients with frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), or FTD plus ALS, ascertained within the European Early-Onset Dementia Consortium. [...]
2017 - 10.1002/humu.23161
Human Mutation, Vol. 38, Issue 3 (March 2017) , p. 297-309  
5.
8 p, 676.9 KB Off-label use of rituximab for systemic lupus erythematosus in Europe IB: speaker fees from MSD and Lilly Netherlands. TD: study support by Roche, UCB and Sanofi; honoraria for scientific advice from Roche, Chugai, Sanofi, Eli Lilly and UCB. FAH and MI: research grants from Roche. DI: acted as an adviser to a number of companies in the past 5 years, including GlaxoSmithKline, Eli Lilly and Roche; the honoraria offered are passed on to a local arthritis charity. RvV: research support and grants. For performing the analyses reported here, which were requested by the European Medicines Agency (EMA), the authors received an unrestricted grant from Roche. Other: AbbVie, Amgen, BMS, GSK, Pfizer, UCB. Consultancy, honoraria: AbbVie, Biotest, BMS, Celgene, Crescendo, GSK, Janssen, Lilly, Merck, Novartis, Pfizer, Roche, UCB and Vertex. / Rydén-Aulin, Monica (Karolinska Institutet, Karolinska University Hospital) ; Boumpas, Dimitrios (Medical School, National and Kapodestrian University of Athens, Attikon University Hospital) ; Bultink, Irene (Amsterdam Rheumatology and Immunology Center) ; Callejas Rubio, Jose Luis (Hospital San Cecilio) ; Caminal-Montero, Luis (Hospital Universitario Central de Asturias) ; Castro, Antoni (University Hospital Sant Joan de Reus, Rovira i Virgili University (URV)-IISPV) ; Colodro Ruiz, Agustín (Pasaje Nueva Victoria, 2, 2do C) ; Doria, Andrea (University of Padova) ; Dörner, Thomas (Charite Universitaetsmedizin Berlin) ; Gonzalez-Echavarri, Cristina (BioCruces Health Research Institute, Cruces University Hospital, University of the Basque Country) ; Gremese, Elisa (Institute of Rheumatology and Affine Sciences (IRSA), Catholic University of the Sacred Heart) ; Houssiau, Frederic A (Cliniques Universitaires Saint-Luc, Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Université Catholique de Louvain) ; Huizinga, Tom (C1-41, Leiden University Medical Center) ; Inanç, Murat (Istanbul University) ; Isenberg, David (University College London, The Rayne Building) ; Iuliano, Annamaria (San Camillo Hospital) ; Jacobsen, Søren (Copenhagen Lupus and Vasculitis Clinic, Center for Rheumatology and Spine Diseases, University of Copenhagen, Rigshospitalet) ; Jimenéz-Alonso, Juan (Universitary 'Virgen de las Nieves' Hospital) ; Kovács, Lászlo (Albert Szent-Györgyi Health Centre, University of Szeged) ; Mariette, Xavier (Rhumatologie Responsable de l'Unité de Recherche Clinique, Hôpitaux Universitaire Paris-Sud, Université Paris-Sud, INSERM U1184) ; Mosca, Marta (Rheumatology Unit, Pisa) ; Nived, Ola (Rheumatology Clinic, Skåne University Hospital) ; Oristrell, Joaquim (Universitat Autònoma de Barcelona. Departament de Medicina) ; Ramos-Casals, Manuel (ICMiD, Josep Font Autoimmune Lab, CELLEX-IDIBAPS) ; Rascón, Javier (Carrer de les Sabateres, 9-1, Alaró) ; Ruiz-Irastorza, Guillermo (BioCruces Health Research Institute, Cruces University Hospital, University of the Basque Country) ; Sáez-Comet, Luis (Unidad de Enfermedades Autoinmunes Sistémicas, Hospital Universitario Miguel Servet de Zaragoza, Paseo Isabel la Católica) ; Salvador Cervelló, Gonzalo (Hospital Universitario y Politecnico La Fe) ; Sebastiani, Gian Domenico (UOC Reumatologia, Ospedale San Camillo, Circonvallazione Gianicolense n. 87) ; Squatrito, Danilo (University of Florence) ; Szücs, Gabriella (Institute of Medicine, University of Debrecen) ; Voskuyl, Alexandre (Amsterdam Rheumatology and Immunology Center (ARC), VU University Medical Center) ; van Vollenhoven, Ronald (Amsterdam Rheumatology and Immunology Center ARC, AMC mail F4-105)
Rituximab (RTX) is a biological treatment used off-label in patients with systemic lupus erythematosus (SLE). This survey aimed to investigate the off-label use of RTX in Europe and compare the characteristics of patients receiving RTX with those receiving conventional therapy. [...]
2016 - 10.1136/lupus-2016-000163
Lupus Science & Medicine, Vol. 3 (september 2016)  
6.
7 p, 354.9 KB Association between cell-bound blood amyloid-β(1-40) levels and hippocampus volume / Sotolongo-Grau, Oscar (Institut Català de Neurociències Aplicades) ; Pesini, Pedro (Araclon Biotech Ltd) ; Valero, Sergi (Hospital Universitari Vall d'Hebron. Departament de Psiquiatría) ; Lafuente, Asunción (Alzheimer Research Center and Memory Clinic) ; Buendía, Mar (Institut Català de Neurociències Aplicades) ; Pérez-Grijalba, Virginia (Araclon Biotech Ltd) ; José, Itziar San (Araclon Biotech Ltd) ; Ibarria, Marta (Institut Català de Neurociències Aplicades) ; Giménez, Joan (Clínica Corachan) ; Hernández, Isabel (Institut Català de Neurociències Aplicades) ; Tárraga, Lluís (Institut Català de Neurociències Aplicades) ; Ruiz, Agustín (Institut Català de Neurociències Aplicades) ; Boada, Mercé (Institut Català de Neurociències Aplicades) ; Sarasa, Manuel (Araclon Biotech Ltd) ; Universitat Autònoma de Barcelona
The identification of early, preferably presymptomatic, biomarkers and true etiologic factors for Alzheimer's disease (AD) is the first step toward establishing effective primary and secondary prevention programs. [...]
2014 - 10.1186/s13195-014-0056-3
Alzheimer's research & therapy, Vol. 6 (october 2014) , p. 56  
7.
6 p, 420.8 KB ATP5H/KCTD2 locus is associated with Alzheimer's disease risk / Boada Rovira, Mercè (Hospital Universitari Vall d'Hebron) ; Antúnez, C. (University Hospital Virgen de la Arrixaca) ; Ramírez Lorca, Repo (Neocodex) ; DeStefano, Anita L. (Boston University School of Medicine) ; González Pérez, A. (Neocodex) ; Gayán, Javier (Neocodex) ; López Arrieta, Jesús (University Hospital La Paz-Cantoblanco) ; Ikram, M. Arfan (Erasmus MC University Medical Center) ; Hernández, Isabel (Institut Català de Neurociències Aplicades) ; Marín, J. (University Hospital Virgen de la Arrixaca) ; Galán, José Jorge (Neocodex) ; Bis, Joshua C. (University of Washington) ; Mauleón, Ana (Institut Català de Neurociènces Aplicades) ; Rosende-Roca, Maitée (Institut Català de Neurociènces Aplicades) ; Moreno Rey, Concha (Neocodex) ; Gudnasson, Vilmundur (Kopavogur University of Iceland) ; Morón, Francisco Jesús (Neocodex) ; Velasco, Juan (Neocodex) ; Carrasco, José Miguel (Neocodex) ; Alegret, Montserrat (Institut Català de Neurociències Aplicades) ; Espinosa, Ana (Institut Català de Neurociències Aplicades) ; Vinyes, Georgina (Institut Català de Neurociències Aplicades) ; Lafuente, Asunción (Institut Català de Neurociències Aplicades) ; Vargas, Liliana (Institut Català de Neurociències Aplicades) ; Fitzpatrick, Annette L. (University of Washington) ; Launer, Lenore Joy (National Institute on Aging) ; Sáez, María Eugenia (Neocodex) ; Vázquez, Enrique (Neocodex) ; Becker, James T. (University of Pittsburgh) ; López, Oscar L. (University of Pittsburgh School of Medicine) ; Serrano Ríos, Manuel (Hospital Clínico San Carlos) ; Tárraga, Lluís (Institut Català de Neurociènces Aplicades) ; van Duijn, Cornelia M. (Erasmus MC University Medical Center) ; Real, Luis Miguel (Neocodex) ; Seshadri, Sudha (National Heart, Lung and Blood Institute's Framingham Heart Study) ; Ruiz, Agustín (Department of Structural Genomics, Neocodex) ; Universitat Autònoma de Barcelona
To identify loci associated with Alzheimer disease, we conducted a three-stage analysis using existing genome-wide association studies (GWAS) and genotyping in a new sample. In Stage I, all suggestive single-nucleotide polymorphisms (at P <0. [...]
2014 - 10.1038/mp.2013.86
Molecular Psychiatry, Vol. 19, Issue 6 (June 2014) , p. 682-687  

Documents de recerca 1 registres trobats  
1.
226 p, 4.2 MB Factores genéticos asociados a la degeneración lobar frontotemporal. Análisis de susceptibilidad genética y correlación fenotipo-genotipo / Hernández Ruiz, Mª Isabel ; Ruiz Laza, Agustín, dir. ; Boada Rovira, Mercé, dir. ; Blesa Gonzalez, Rafael, dir. ; Álvarez Sabin, José ; Universitat Autònoma de Barcelona. Departament de Medicina
La Degeneración Lobar Frontotemporal es un grupo heterogéneo de enfermedades, la segunda causa más frecuente de demencia en edad presenil y la que presenta el mayor número de casos hereditarios. Se caracteriza por una gran variabilidad clínica, genética e histopatológica. [...]
Frontotemporal Lobar Degeneration is a heterogeneous group of disorders, the second most frequent cause of early dementia and the one with the highest number of inherited cases. It is characterized by considerable variability in clinical, genetic and histopathologic features. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2015  

Vegeu també: autors amb noms similars
26 Ruiz, A.
2 Ruiz, Adriana
1 Ruiz, Adrià
1 Ruiz, Adrián
8 Ruiz, Agustin
1 Ruiz, Aida
1 Ruiz, Albert
2 Ruiz, Alberto
2 Ruiz, Alejandro
1 Ruiz, Alejandro A.
5 Ruiz, Alfredo
73 Ruiz, Alfredo,
1 Ruiz, Alfredo, (Ruiz Panadero)
3 Ruiz, Amparo
2 Ruiz, Analia
5 Ruiz, Anna
1 Ruiz, Anne
3 Ruiz, Antonio
1 Ruiz, Àlex
3 Ruíz, Antonio
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.